Cannabis Testing Market: Market Size & Forecast 2026

The cannabis testing market provides critical analytical services and instrumentation to verify the chemical composition, safety, and quality of cannabis and cannabis-derived products. As of 2025, the global market is valued at approximately $6.32 billion, with projections indicating substantial expansion through the decade. Testing services cover potency analysis, contamination screening for pesticides and heavy metals, microbial testing, and terpene profiling to ensure compliance with evolving regulatory frameworks.

• •Market valued at $6.32 billion in 2025 with 19.8% projected CAGR
• •Testing services include potency, contamination, and quality analysis
• •Services serve cultivators, processors, and manufacturers across the supply chain

The primary catalyst for market expansion is the ongoing legalization of cannabis for medical and recreational use across North America, Europe, and parts of Asia-Pacific. Stringent regulatory mandates requiring mandatory testing for contaminants, potency, and purity have made laboratory services essential for industry participants. Additionally, rising consumer awareness and demand for product safety and transparency are pushing companies to implement rigorous testing protocols throughout the supply chain.

• •Expanding global legalization of medical and recreational cannabis
• •Stringent regulatory mandates requiring mandatory product testing
• •Growing consumer demand for safety transparency and quality assurance

The market is segmented by testing type including potency testing, terpene profiling, heavy metal testing, pesticide screening, microbial testing, and residual solvent analysis, as well as by product type encompassing instruments, consumables, and laboratory services. North America currently dominates the market due to early and widespread legalization, particularly in the United States and Canada, while Europe represents a significant and growing regional segment. The Asia-Pacific region is emerging as a developing market driven by growing acceptance of medical cannabis in countries including Australia, Thailand, and South Korea.

• •Segments include potency testing, contamination screening, and quality analysis
• •North America leads due to widespread legalization in the US and Canada
• •Europe and Asia-Pacific represent growing markets as legalization expands

What are the recent trends and outlook?

Technological advancements in analytical instrumentation, including portable testing devices and high-throughput screening systems, are improving testing speed, accuracy, and accessibility for industry participants. The market is expected to continue its strong growth trajectory, with projections indicating potential market value exceeding $10.86 billion by 2028, driven by new market entrants, evolving regulatory standards, and continued legalization efforts. Future growth will be supported by standardization of testing protocols, expansion into new geographic markets, and increasing demand for comprehensive quality assurance across the entire cannabis supply chain.

• •Advances in portable devices and high-throughput screening improving testing accessibility
• •Market projected to exceed $10.86 billion by 2028 at 19.8% CAGR
• •Future growth supported by protocol standardization and geographic market expansion